BY Scott Merville

Natural killer cells sound menacing, but they play a friendly role in keeping us healthy. And they might do much more in stopping cancer.

After years of diligent, groundbreaking research, MD Anderson physician-scientists are putting natural killer cells – NK cells for short – to work in a series of clinical trials for a variety of cancers through the cancer center’s Moon Shots Program™.

“These white...

Natural killer cells derived from cord blood used to kill blood cancers

BY Ronda Wendler

When Jo Ann West learned she had early-stage breast cancer, her doctor suggested an inventive new treatment that involves no major surgery...

BY Scott Merville

After all 13 breast cancer patients in a first-of-its-kind clinical trial responded positively to a new targeted therapy, MD Anderson researchers...

BY Clayton Boldt, Ph.D.

Researchers have found that the human papillomavirus (HPV) vaccine may reduce the rate of oral HPV infections in young adults by as much as 88%. However, given the vaccine’s low rate of uptake in the U.S. – especially in males – the impact of the vaccine on oral HPV infections remains low.

This is the first study to explore the possible impact of HPV vaccination on oral HPV infections. The findings were presented by Maura...

HPV vaccine shown to be effective against oral infection

BY Sarah Bronson

Two new clinical trials at MD Anderson are taking aim at mantle cell lymphoma – a rare form of non-Hodgkin’s lymphoma.

Most mantle...

BY Ron Gilmore

What if you or a loved one had cancer but were denied access to a research study testing a poten-tially beneficial treatment?


BY Ron Gilmore

There are many moving parts when it comes to the mechanics of how otherwise healthy cells are transformed into those that cause deadly cancers...

BY Clayton Boldt, Ph.D.

More than 50 years after the U.S. Surgeon General first warned about the dangers of cigarettes, smoking rates have plummeted.